BEXEL Biotechnology, Inc.
Three sectors of BEXEL are as follow:
- BEXEL-Kits, Reagents and Services
- BEXEL-Pharmaceuticals
- BEXEL-Alternative Medicines
BEXEL is actively engaged in developing proprietary novel kits and reagents utilized by biotechnology and pharmaceutical industries in the field of Electrophoresis, Electro-blotting, Protein Biochemistry and Proteomics. As of to-date, BEXEL has introduced 12 products and market these products directly as well as through distributors world-wide. The company has so far 16 distributors in 10 countries.
In late 2000, BEXEL has developed a trade-secret technology platform utilizing molecular algorithms in combination with quantitative structure activity relation (QSAR) for developing new class of orally active drugs for the treatment of various chronic diseases. The company's technology involves generation of new molecules by combining properties of isolated natural product molecules. This technology allowed the company to create Smart-Leads that eliminates all less-fit candidates without going through un-predicted lead isolation methods. Utilizing BEXEL's resource bank of natural product molecules predominantly from Chinese and Indian origin, the company has already identified three molecules for the treatment of metabolic and inflammatory diseases. All leads under development by BEXEL-Pharmaceuticals are synthetic orally active small molecules that are completely independent of source extracts with "Composition-of-Matter" patents.
In year 2001, BEXEL has entered with its substantial expertise in formulation to commercialize orally active natural product extracts as Alternative Medicines for the treatment of chronic Metabolic, Inflammatory, Allergy and Neurological diseases. These alternative medicines are being formulated and patented with enormous strength of the company's scientific, clinical and pharmaceutical developmental skills. The current three products under development are for Diabetes, Alzheimer and Allergic Rhinitis. BEXEL is in the process of establishing a manufacturing R & D facility in India to accomplish its mission in the field of Alternative Medicines.